Cargando…

Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model

Identification of novel molecular adjuvants which can boost and enhance vaccine-mediated immunity and provide dose-sparing potential against complex infectious diseases and for immunotherapy in cancer is likely to play a critical role in the next generation of vaccines. Given the number of challengi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Louis, Lumena, Wise, Megan C., Choi, Hyeree, Villarreal, Daniel O., Muthumani, Kar, Weiner, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6632123/ https://www.ncbi.nlm.nih.gov/pubmed/31121939 http://dx.doi.org/10.3390/vaccines7020042

Ejemplares similares

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2019)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018)

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
por: Zankharia, Urvi S., et al.
Publicado: (2020)

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus
por: Esquivel, Rianne N., et al.
Publicado: (2019)

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus
por: Choi, Hyeree, et al.
Publicado: (2020)

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017)

DNA repair and synthetic lethality
por: Guo, Gong-she, et al.
Publicado: (2011)

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
por: Choi, Hyeree, et al.
Publicado: (2019)

Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus
por: Muthumani, Karuppiah, et al.
Publicado: (2016)

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
por: Khoshnejad, Makan, et al.
Publicado: (2019)

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
por: Xu, Ziyang, et al.
Publicado: (2020)

In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
por: Patel, Ami, et al.
Publicado: (2018)

Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
por: Khoshnejad, Makan, et al.
Publicado: (2020)

Evolving DNA repair synthetic lethality targets in cancer
por: Kulkarni, Sanat, et al.
Publicado: (2022)

Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity
por: Schultheis, Katherine, et al.
Publicado: (2020)

Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice
por: Scott, Veronica L, et al.
Publicado: (2015)

DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
por: Elliott, Sarah T. C., et al.
Publicado: (2017)

Synthetic Lethality between DNA Polymerase Epsilon and RTEL1 in Metazoan DNA Replication
por: Bellelli, Roberto, et al.
Publicado: (2020)

Protective immunity by an engineered DNA vaccine for Mayaro virus
por: Choi, Hyeree, et al.
Publicado: (2019)

Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
por: Pinoli, Pietro, et al.
Publicado: (2021)

Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
por: Kciuk, Mateusz, et al.
Publicado: (2022)

P16-36. Functional genomic immune profile of SIV DNA vaccines delivered by electroporation and combined with molecular adjuvants
por: Boyer, JD, et al.
Publicado: (2009)

An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model
por: Patel, Ami, et al.
Publicado: (2017)

DNA vaccination protects mice against Zika virus-induced damage to the testes
por: Griffin, Bryan D., et al.
Publicado: (2017)

DNA as an Adjuvant: Capacity of Insect DNA and Synthetic Oligodeoxynucleotides to Augment T Cell Responses to Specific Antigen
por: Sun, Siquan, et al.
Publicado: (1998)

G-Quadruplex DNA as a Molecular Target for Induced Synthetic Lethality in Cancer Cells
por: McLuckie, Keith I. E., et al.
Publicado: (2013)

Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer?
por: Lazo, Pedro A.
Publicado: (2022)

Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
por: Wojtak, Krzysztof, et al.
Publicado: (2019)

In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity
por: Xu, Ziyang, et al.
Publicado: (2020)

436. Developing a Synthetic DNA Vaccine for an Emerging Pathogen - Middle East Respiratory Syndrome
por: Reuschel, Emma L., et al.
Publicado: (2016)

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity
por: Shedlock, Devon J., et al.
Publicado: (2014)

Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses
por: Thorne, Amy Haseley, et al.
Publicado: (2020)

Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
por: Ali, Reem, et al.
Publicado: (2021)

Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461
por: Masud, Tehmina, et al.
Publicado: (2021)

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
por: Mandal, Jayaprakash, et al.
Publicado: (2022)

Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants
por: Fuentes, Roberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_249tjfnhq0uhi7ebk0p13cc728